Torrent Pharmaceuticals Ltd. (TORP)

Currency in INR
3,628.15
+14.40(+0.40%)
Closed·
TORP Scorecard
Full Analysis
Impressive gross profit margins
TORP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,590.653,635.20
52 wk Range
2,891.453,790.00
Key Statistics
Bid/Ask
3,628.15 / 3,700.00
Prev. Close
3,613.75
Open
3,624.8
Day's Range
3,590.65-3,635.2
52 wk Range
2,891.45-3,790
Volume
2.19K
Average Volume (3m)
14.04K
1-Year Change
8.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TORP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3,937.04
Upside
+8.51%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Torrent Pharmaceuticals Ltd. Company Profile

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Employees
17059
Market
India

Compare TORP to Peers and Sector

Metrics to compare
TORP
Peers
Sector
Relationship
P/E Ratio
61.1x30.9x−0.5x
PEG Ratio
3.990.940.00
Price/Book
16.1x5.2x2.6x
Price / LTM Sales
10.3x4.4x3.3x
Upside (Analyst Target)
10.3%12.1%42.9%
Fair Value Upside
Unlock−1.2%6.2%Unlock

Analyst Ratings

19 Buy
6 Hold
1 Sell
Ratings:
26 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3,937.04
(+8.51% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 59.15%
Dividend Yield
0.88%
Industry Median 0.74%
Annualised payout
32.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 28, 2025
EPS / Forecast
16.50 / 17.13
Revenue / Forecast
31.78B / 31.50B
EPS Revisions
Last 90 days

TORP Income Statement

People Also Watch

3,236.50
MAHM
+1.58%
2,963.80
TVSM
-0.58%
380.35
BAJE
-0.92%
4,409.40
HIAE
-0.80%
7,236.50
APLH
-0.31%

FAQ

What Stock Exchange Does Torrent Pharmaceuticals Ltd. Trade On?

Torrent Pharmaceuticals Ltd. is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Torrent Pharmaceuticals Ltd.?

The stock symbol for Torrent Pharmaceuticals Ltd. is "TORP."

What Is the Torrent Pharmaceuticals Ltd. Market Cap?

As of today, Torrent Pharmaceuticals Ltd. market cap is 1.23T.

What Is Torrent Pharmaceuticals Ltd.'s Earnings Per Share (TTM)?

The Torrent Pharmaceuticals Ltd. EPS (TTM) is 59.15.

When Is the Next Torrent Pharmaceuticals Ltd. Earnings Date?

Torrent Pharmaceuticals Ltd. will release its next earnings report on 21 Oct 2025.

From a Technical Analysis Perspective, Is TORP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Torrent Pharmaceuticals Ltd. Stock Split?

Torrent Pharmaceuticals Ltd. has split 3 times.

How Many Employees Does Torrent Pharmaceuticals Ltd. Have?

Torrent Pharmaceuticals Ltd. has 17059 employees.

What is the current trading status of Torrent Pharmaceuticals Ltd. (TORP)?

As of 12 Aug 2025, Torrent Pharmaceuticals Ltd. (TORP) is trading at a price of 3,628.15, with a previous close of 3,613.75. The stock has fluctuated within a day range of 3,590.65 to 3,635.20, while its 52-week range spans from 2,891.45 to 3,790.00.

What Is Torrent Pharmaceuticals Ltd. (TORP) Price Target According to Analysts?

The average 12-month price target for Torrent Pharmaceuticals Ltd. is INR3937.03846, with a high estimate of INR4380 and a low estimate of INR3425. 19 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +8.51% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.